Jump to main content
Jump to site search

Issue 10, 2018
Previous Article Next Article

Noninvasive and prospective diagnosis of coronary heart disease with urine using surface-enhanced Raman spectroscopy

Author affiliations

Abstract

A prospective diagnosis method for coronary heart disease (CHD) using human urine based on surface-enhanced Raman spectroscopy (SERS) is proposed, and could provide valuable information for judging whether to perform percutaneous coronary intervention (PCI) in clinics. Here, urine samples from 87 patients with CHD, including patients with PCI before operation (degree of cardiovascular congestion above 70%) and without PCI (degree of cardiovascular congestion under 70%), and 20 healthy humans were measured using SERS. Principal component analysis (PCA) combined with linear discriminant analysis (LDA) was employed to analyze the SERS spectra, revealing that the classification sensitivity and specificity were 90% and 78.9%, respectively, and the absolute value for loading of PC1 at 1509 cm−1 was the largest. Since platelet-derived growth factor-BB (PDGF-BB) is closely related to CHD, PDGF-BB aqueous solutions with various concentrations (1, 0.5, 0.1, 0.05 and 0.01 ppm) and a mixture of healthy human urine and PDGF-BB aqueous solutions were then investigated in this work, and it was found that the Raman peak at 1509 cm−1 may be attributed to PDGF-BB. Moreover, the measured SERS spectra of all the urine samples from the 87 patients with CHD were compared with the clinical data provided by a hospital, and it was revealed that the appearance of a peak at 1509 cm−1 in the SERS spectra was in good agreement with the results of coronary angiography tests when cardiovascular congestion was above 70%. This indicated that the classification sensitivity and specificity were 87.9% and 87.0%, respectively, through identification of the Raman peak at 1509 cm−1.

Graphical abstract: Noninvasive and prospective diagnosis of coronary heart disease with urine using surface-enhanced Raman spectroscopy

Back to tab navigation

Supplementary files

Publication details

The article was received on 14 Dec 2017, accepted on 15 Mar 2018 and first published on 16 Mar 2018


Article type: Paper
DOI: 10.1039/C7AN02022H
Citation: Analyst, 2018,143, 2235-2242
  •   Request permissions

    Noninvasive and prospective diagnosis of coronary heart disease with urine using surface-enhanced Raman spectroscopy

    H. Yang, C. Zhao, R. Li, C. Shen, X. Cai, L. Sun, C. Luo and Y. Yin, Analyst, 2018, 143, 2235
    DOI: 10.1039/C7AN02022H

Search articles by author

Spotlight

Advertisements